Michael T. Hemann - Concepedia

Author

Michael T. Hemann

Massachusetts Institute of Technology ORCID

Also Known As

Cordon-Cardo, Carlos, David Wiest, Hemann, M. T., Hemann, Michael, Hemann, Michael T., Hemann, Michael, T, Lauffenburger, Douglas A, M T Hemann, M. Hemann, M. T. Hemann

310

Publications

17.3K

Citations

H-Index

111

Concepts

All Affiliations

Massachusetts Institute of Technology Harvard University Dana-Farber Cancer Institute Howard Hughes Medical Institute Cold Spring Harbor Laboratory

About

Michael T. Hemann is an author at Massachusetts Institute of Technology specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	43	53	13.6K
2	Health Sciences	6	6	942
3	Natural Sciences	5	5	723
4	Biochemistry	5	5	691
5	Engineering	2	2	157

Michael T. Hemann

Publications

16.6K

Citations

H-Index

Page 1

	Year	Citations
A microRNA polycistron as a potential human oncogene Lin He, J. Michael Thomson, Michael T. Hemann, Nature Microrna PolycistronGeneticsMicrorna DetectionSmall RnaGene Expression	2005	3.5K
The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability Michael T. Hemann, Margaret A. Strong, Ling-Yang Hao, Cell ChromatinGenome InstabilityChromosome StabilityCell DivisionGenetics	2001	1.2K
Disrupting the Pairing Between <i>let-7</i> and <i>Hmga2</i> Enhances Oncogenic Transformation Christine Mayr, Michael T. Hemann, David P. Bartel Science Let-7 MirnaSystems BiologySignal TransductionMirna-directed RepressionGenetics	2007	1.1K
Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control Eva Hernando, Zaher Nahlé, Gloria Juan, Nature ChromatinGenome InstabilityCell RegulationCell DivisionGenetics	2004	562
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors Ross A. Dickins, Michael T. Hemann, Jack T. Zilfou, Nature Genetics Tumor PhenotypesGene ExpressionMicrorna DetectionSmall RnaSystems Biology	2005	523
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress Peter M. Bruno, Yunpeng Liu, Ga Young Park, Nature Medicine Reductive StressApoptosisRibosome Biogenesis StressCell DeathRadiation Oncology	2017	510
Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants Michael T. Hemann, Anka Bric, Julie Teruya‐Feldstein, Nature Tumor HeterogeneityMedicineTumour-derived Myc MutantsTumor SuppressorRadiation Oncology	2005	449
DNA Damage-Mediated Induction of a Chemoresistant Niche Luke A. Gilbert, Michael T. Hemann Cell Genome InstabilityDna DamageNatural SciencesGeneticsGenomic Mechanism	2010	420
The p53–Bcl-2 connection Michael T. Hemann, Scott W. Lowe Cell Death and Differentiation Cell RegulationP53–bcl-2 ConnectionMolecular BiologyCell DeathTumor Suppressor	2006	359
An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo Michael T. Hemann, Jordan S. Fridman, Jack T. Zilfou, Nature Genetics Tumor BiologyDistinct Tumor PhenotypesTumor HeterogeneityStable RnaiMedicine	2003	349

Page 1